Literature DB >> 3813595

Malignant melanoma of mucous membranes. A clinicopathologic study of 13 cases in Japanese patients.

T Kato, H Takematsu, Y Tomita, M Takahashi, R Abe.   

Abstract

We found 13 mucosal melanomas (13%) among 103 cases of malignant melanoma at Tohoku University Hospital, Sendai, Japan, a high incidence. Five melanomas were found on the oral mucosa, another five on the genital mucosa, two within the nasal cavity, and one on the esophagus. Three of the melanomas on the oral mucosa occurred on the lip and the other two on the gingiva. A striking prevalence of melanomas was observed in women, the male-to-female ratio being 0.08. Histologic examination revealed that 58% of the melanomas were characterized by lentiginous, 23% by nodular, and 15% by superficial spreading proliferation. Most of the melanomas were Clark's level IV or V at the time of diagnosis. Except for three who have been under observation for a short time, all the patients have died. There appear to be some clinical and histologic similarities between mucosal melanoma and melanoma of the volar skin, but the difference in biological behavior warrants that the two be classified separately.

Entities:  

Mesh:

Year:  1987        PMID: 3813595

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

Review 1.  Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features.

Authors:  Emily A Merkel; Pedram Gerami
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

2.  Immunolocalization and distribution patterns of type IV collagen alpha chains in oral mucosal melanoma.

Authors:  Hitoshi Nagatsuka; Rosario Santos Rivera; Mehmet Gunduz; You-Jin Lee; Ryo Tamamura; Esra Gunduz; Ichiro Naito; Yoshikazu Sado; Noriyuki Nagai
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

Review 3.  Mucosal melanomas: a case-based review of the literature.

Authors:  Nagashree Seetharamu; Patrick A Ott; Anna C Pavlick
Journal:  Oncologist       Date:  2010-06-22

4.  Genetic markers of oral malignant melanoma analysed by fluorescence in situ hybridisation (FISH).

Authors:  Chiara Baldovini; Anna L Tosi; Enrico Di Oto; Camilla Reggiani; Susanna Cappia; Christine M Betts; Carmine Gallo; Lisa Ricchieri; Roberto Cocchi; Maria P Foschini
Journal:  Virchows Arch       Date:  2011-06-29       Impact factor: 4.064

5.  Anorectal melanoma with a KIT-activating mutation, which is a target for tyrosine kinase inhibitor.

Authors:  Miki Itoh; Akira Goto; Hideki Wakasugi; Yutaka Yoshida; Yasutaka Matsunaga; Kenichi Fujii; Kazuya Suzuki; Kazuhiko Yonezawa; Takashi Abe; Yoshiaki Arimura; Yasuhisa Shinomura
Journal:  Int J Clin Oncol       Date:  2010-11-11       Impact factor: 3.402

6.  Oral Malignant Melanoma in a Patient With Neurofibromatosis Type 1: An Extremely Rare Association.

Authors:  Soufiane Berhili; Mohammed Rezzoug; Ahmed Ben Sghier; Mohammed Moukhlissi; Loubna Mezouar
Journal:  Cureus       Date:  2022-05-25

7.  Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study.

Authors:  Hyo Song Kim; Eun Kyoung Kim; Hyun Jung Jun; Sung Yong Oh; Keon Woo Park; Do Hyoung Lim; Soon Il Lee; Jung Han Kim; Kyoung Mee Kim; Dae Ho Lee; Jeeyun Lee
Journal:  BMC Cancer       Date:  2010-04-28       Impact factor: 4.430

8.  Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma.

Authors:  Hee Kyung Kim; Sunyoung Lee; Kyung Kim; Mi Hwa Heo; Hansang Lee; Jinhyun Cho; Nayoung K D Kim; Woongyang Park; Su Jin Lee; Jung Han Kim; Kee-Taek Jang; Sang-Hee Choi; Jeeyun Lee
Journal:  Transl Oncol       Date:  2016-11-22       Impact factor: 4.243

9.  Sinonasal Melanoma: A Case Report and Literature Review.

Authors:  I S S Alves; L G S Berriel; R T Alves; M B Pinto; C F P Oliveira; A C Cazzotto; W V Moura
Journal:  Case Rep Oncol Med       Date:  2017-01-31

10.  Anorectal melanoma: surgical management guidelines according to tumour thickness.

Authors:  G H Weyandt; A O Eggert; M Houf; F Raulf; E B Bröcker; J C Becker
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.